These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 18543799)

  • 1. [Italian guidelines on cardiac rehabilitation and secondary prevention of cardiovascular disease: executive summary].
    Griffo R; Urbinati S; Giannuzzi P; Jesi AP; Sommaruga M; Sagliocca L; Bianco E; Tassoni G; Iannucci M; Sanges D; Baldi C; Rociola R; Carbonelli MG; Familiari MG; ; ; ; ; Cristinziani GR; Amari C; Richichi I; Alessandrini F; Mordenti F; Mauro B; Mozzetta S; Miglioretti M; Buchberger R; Cammarano R; Sampaolo L; Pellegrini L; Rusticali B; Mele A; Ceci V; Chieffo C; Bolognese L; Schweiger C; Michielin P; Baglio G; Nobile A; Scrutinio D; Vigorito C
    G Ital Cardiol (Rome); 2008 Apr; 9(4):286-97. PubMed ID: 18543799
    [No Abstract]   [Full Text] [Related]  

  • 2. [The Italian SurveY on carDiac rEhabilitation 2008 (ISYDE 2008): study presentation].
    Tramarin R; Ambrosetti M; De Feo S; Griffo R; Maslowsky F; Diaco T; ; Piepoli M; Riccio C
    G Ital Cardiol (Rome); 2008 Jul; 9(7):497-503. PubMed ID: 18678216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of risk factor modification through cardiac rehabilitation.
    Borrás IC; Cruz-Jiménez M; Nadal E; Middelhoff A; Rivera A
    Bol Asoc Med P R; 2008; 100(4):75-9. PubMed ID: 19400532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heart groups in Germany-current situation and prospects].
    Bjarnason-Wehrens B; Held K; Karoff M
    Herz; 2006 Sep; 31(6):559-65. PubMed ID: 17036187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-engineering cardiac rehabilitation programmes: considering the patient's point of view.
    Pâquet M; Bolduc N; Xhignesse M; Vanasse A
    J Adv Nurs; 2005 Sep; 51(6):567-76. PubMed ID: 16129007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum.
    Smith SC; Jackson R; Pearson TA; Fuster V; Yusuf S; Faergeman O; Wood DA; Alderman M; Horgan J; Home P; Hunn M; Grundy SM
    Circulation; 2004 Jun; 109(25):3112-21. PubMed ID: 15226228
    [No Abstract]   [Full Text] [Related]  

  • 7. [When should we start the treatment of the cardiovascular risk factors].
    de Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2008; 125(1):125-36; discussion 136-44. PubMed ID: 18777847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiac rehabilitation. Its historical evolution and current situation].
    Velasco Rami JA; Maroto Montero JM
    Rev Esp Cardiol; 1995; 48 Suppl 1():1-7. PubMed ID: 7644814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing multiple cardiovascular risk factors.
    Blank RC; Brunton S
    J Fam Pract; 2008 Mar; 57(3 Suppl Managing):S13-20. PubMed ID: 18664333
    [No Abstract]   [Full Text] [Related]  

  • 10. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.
    Giannuzzi P; Temporelli PL; Marchioli R; Maggioni AP; Balestroni G; Ceci V; Chieffo C; Gattone M; Griffo R; Schweiger C; Tavazzi L; Urbinati S; Valagussa F; Vanuzzo D;
    Arch Intern Med; 2008 Nov; 168(20):2194-204. PubMed ID: 19001195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rehabilitation after ST-elevation myocardial infarction: inpatient, outpatient or none?].
    Hoberg E
    Dtsch Med Wochenschr; 2004 Feb; 129(7):317-20. PubMed ID: 14765331
    [No Abstract]   [Full Text] [Related]  

  • 12. [European practice guidelines on prevention of cardiovascular diseases: executive summary].
    Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; ;
    G Ital Cardiol (Rome); 2008 Jan; 9(1):11-59. PubMed ID: 18383763
    [No Abstract]   [Full Text] [Related]  

  • 13. The challenge for preventive cardiology.
    Kotseva K; Wood D
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S19-23. PubMed ID: 19675431
    [No Abstract]   [Full Text] [Related]  

  • 14. Antioxidant vitamin supplements and cardiovascular disease.
    Kris-Etherton PM; Lichtenstein AH; Howard BV; Steinberg D; Witztum JL;
    Circulation; 2004 Aug; 110(5):637-41. PubMed ID: 15289389
    [No Abstract]   [Full Text] [Related]  

  • 15. Achievement of secondary preventive goals after acute myocardial infarction: a comparison between participants and nonparticipants in a routine patient education program in Sweden.
    Bellman C; Hambraeus K; Lindbäck J; Lindahl B
    J Cardiovasc Nurs; 2009; 24(5):362-8. PubMed ID: 19652617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heart of the matter: reducing CVD risk.
    Hayman LL; Kamau MW; Stuart-Shor EM
    Nurse Pract; 2009 May; 34(5):30-5. PubMed ID: 19390396
    [No Abstract]   [Full Text] [Related]  

  • 17. Toward optimal health: the experts discuss cardiovascular disease. Interviewed by Jodi R. Godfrey.
    Bairey Merz CN; Hayes SN
    J Womens Health (Larchmt); 2005; 14(1):4-10. PubMed ID: 15692270
    [No Abstract]   [Full Text] [Related]  

  • 18. The importance of managing cardiovascular risk in the treatment of hypertension: the role of ACE inhibitors and ARBs.
    Pierson CA; Epstein BJ; Roberts ME
    J Am Acad Nurse Pract; 2008 Nov; 20(11):529-38. PubMed ID: 19128336
    [No Abstract]   [Full Text] [Related]  

  • 19. Stair use for cardiovascular disease prevention.
    Meyer P; Kayser B; Mach F
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S17-8. PubMed ID: 19675430
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary prevention of cardiovascular disease in different primary healthcare systems with and without pay-for-performance.
    Cupples ME; Byrne MC; Smith SM; Leathem CS; Murphy AW
    Heart; 2008 Dec; 94(12):1594-600. PubMed ID: 18701532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.